A Phase Ib/II Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Brentuximab vedotin; Carboplatin; Etoposide; Ifosfamide; Mesna; Rituximab
- Indications Diffuse large B cell lymphoma; Hodgkin's disease; Lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms PembroHeme
- 19 Feb 2016 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 13 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 08 Apr 2015 New trial record